Abstract:Background: FOXG1-related encephalopathy, also known as FOXG1 syndrome or FOXG1-related disorder, affects most aspects of development and causes microcephaly and brain malformations. This syndrome was previously considered to be the congenital variant of Rett syndrome. The abnormal function or expression of FOXG1, caused by intragenic mutations, microdeletions or microduplications, was considered to be crucial pathological factor for this disorder. Currently, most of the FOXG1-related encephalopathies have been identified in Europeans and North Americans, and relatively few Chinese cases were reported. Methods: Array-Comparative Genomic Hybridization (Array-CGH) and whole-exome sequencing (WES) were carried out for the proband and her parent to detect pathogenic variants. Results: A de novo nonsense mutation (c.385G>T, p.Glu129Ter) of FOXG1 was identified in a female child in a cohort of 73 Chinese children with neurodevelopmental disorders/intellectual disorders (NDDs/IDs). In order to have a comprehensive view of FOXG1-related encephalopathy in China, relevant published reports were browsed and twelve cases with mutations in FOXG1 or copy number variants (CNVs) involving FOXG1 gene were involved in the analysis eventually. Feeding difficulties, seizures, delayed speech, corpus callosum hypoplasia and underdevelopment of frontal and temporal lobes occurred in almost all cases. Out of the 12 cases, eight patients (66.67%) had single-nucleotide mutations of FOXG1 gene and four patients (33.33%) had CNVs involving FOXG1 (3 microdeletions and 1 microduplication). The expression of FOXG1 could also be potentially disturbed by deletions of several brain-active regulatory elements located in intergenic FOXG1-PRKD1 region. Further analysis indicated that PRKD1 might be a cooperating factor to regulate the expression of FOXG1, MECP2 and CDKL5 to contribute the RTT/RTT-like disorders. Discussion: This re-analysis would broaden the existed knowledge about the molecular etiology and be helpful for diagnosis, treatment, and gene therapy of FOXG1-related disorders in the future.

Structural Basis for DNA Recognition by FOXG1 and the Characterization of Disease-causing FOXG1 Mutations

Toward a mechanistic understanding of DNA binding by forkhead transcription factors and its perturbation by pathogenic mutations

FOXN Transcription Factors: Regulation and Significant Role in Cancer.

FOXN Transcription Factors: Regulation and Significant Role in Cancer

Mechanistic Insights into the Preference for Tandem Binding Sites in DNA Recognition by FOXM1

Functional analysis and the molecular dissection of zinc-fingers and homeoboxes 1 (ZHX1).

Mechanism of forkhead transcription factors binding to a novel palindromic DNA site

The forkhead DNA-binding domain binds specific G2-rich RNA sequences

The Role of Forkhead Box Family in Bone Metabolism and Diseases

Human FOX gene family (Review)

Identification of a de novo mutation of the FOXG1 gene and comprehensive analysis for molecular factors in Chinese FOXG1-related encephalopathies

Domain tethering impacts dimerization and DNA-mediated allostery in the human transcription factor FoxP1

The Pathognomonic FOXL2 C134W Mutation Alters DNA-Binding Specificity

Case Report: FOXP1 Syndrome Caused by a De Novo Splicing Variant (c.1652+5 G>A) of the FOXP1 Gene.

Guiding the pioneer

Unraveling the folding and dimerization properties of the human FoxP subfamily of transcription factors

FOXM1: Functional Roles of FOXM1 in Non-Malignant Diseases

Paving Therapeutic Avenues for FOXG1 Syndrome: Untangling Genotypes and Phenotypes from a Molecular Perspective

Dissecting multifunctional roles of forkhead box transcription factor D1 in cancers

FOXO1 promotes the expression of canonical WNT target genes in examined basal-like breast and glioblastoma multiforme cancer cells

Conditional Deletion of Foxg1 Delayed Myelination during Early Postnatal Brain Development